Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04757753
Other study ID # 20/001
Secondary ID 2020-A01790-39-P
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date November 6, 2020
Est. completion date July 2026

Study information

Verified date March 2023
Source Septodont
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study design is a multicentric randomized controlled non-inferiority trial. 160 subjects (teeth) requiring a primary or a secondary root canal treatment will be enrolled in 2 groups (80 in each group). The aim of the study is to assess the efficacy rate and the safety 2 years after root canal obturation undertaken using a ready-to-use calcium silicate sealer (PA1704) compared to the control calcium silicate sealer BioRoot™ RCS. Procedures of root canal treatment will be conventional and standardized for all investigational centers. The canals will be cleaned, shaped and then obturated using a calcium silicate sealer (the ready to use sealer PA1704 or BioRoot™ RCS) with a single cone technique or cold lateral condensation of gutta-percha. Follow-up assessments will be conducted at 6, 12 and 24 months in both groups. The performance and safety of the sealer PA1704 will also be evaluated at 3.5 and 5 years after surgery. Retroalveolar radiographs will be taken at each study visit. The preoperative, postoperative and follow-up clinical and radiographic data will be analyzed.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 160
Est. completion date July 2026
Est. primary completion date August 29, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult male or female (age = 18 years) - Patient requiring a primary or a secondary root canal obturation on a single or multi-rooted tooth, - Patient geographically stable who can be followed by the same investigator site for 2 years, - Informed consent signed, - Patient with social protection Exclusion Criteria: - Patient with one or more documented contraindication to endodontic treatment, - Contraindication to the use of calcium silicate root canal sealer, such as an immature tooth or a known hypersensitivity to one component of the sealer formula, - Endodontic treatment on tooth with calcified root canal assessed radiographically, - Endodontic treatment on tooth with suspected perforation, - Patient with an uncontrolled systemic disease such as diabetes or thyroid disorders, or with an immunocompromised condition or who has undergone radiation therapy to the jaw. - Patient suffering from uncontrolled active periodontitis, not supported - Participation to another interventional clinical study at the same time, - Vulnerable subjects referred to in articles L.1121-5 to 8 and L.1122-1-2 of the Public Health Code and article 66 of Regulation (EU) 2017/745 on medical devices are excluded from the investigation (such as known pregnancy or lactation, patients with legal protection).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ready-to-use root canal sealer: PA1704
The participant will be treated with the ready-to-use root canal sealer (PA1704) in combination with gutta percha.
root canal sealer: BioRoot™ RCS
The participant will be treated with BioRoot™ RCS sealer in combination with gutta percha.

Locations

Country Name City State
Belgium Cliniques Universitaires Saint-Luc, Département de Médecine Dentaire et de Stomatologie Bruxelles
France Centre de santé dentaire Flandre Paris
France Cabinet dentaire Rennes
France Cabinet dentaire Jeanne d'Arc Rouen
France Cabinet dentaire Saint-Grégoire

Sponsors (2)

Lead Sponsor Collaborator
Septodont Slb Pharma

Countries where clinical trial is conducted

Belgium,  France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy rate of root canal obturation Efficacy rate of root canal obturation using clinical and radiological criteria. The radiographic criterion will be assessed by blinded evaluators. The efficacy rates will be compared between the 2 groups. 24 months post-treatment
Secondary Efficacy rate of root canal obturation Efficacy rate of root canal obturation using clinical and radiological criteria. The radiographic criterion will be assessed by blinded evaluators. The efficacy rates will be compared between the 2 groups at 6 and 12-months post-treatment.
The efficacy rate after 3.5 and 5 years will measured only in the PA1704 group.
6-, 12-months, 3.5 and 5 years post-treatment
Secondary Radiological evaluation of the canal obturation Radiological evaluation of the level of apical obturation and density baseline, 6-, 12-, 24-months, 3.5 and 5 years post-treatment
Secondary Postoperative pain The pain is assessed by patients in a diary using a Visual Analogue Scale (VAS: 0-100 mm) at different times after endodontic treatment (at the end of the root canal obturation, 12h postoperative, 24h, Day 2, Day 3, Day 7). The maximum pain felt will be compared between the 2 groups. from the end of the root canal treatment (Day 0) to Day 7.
Secondary Use of oral pain treatment Patients reported the consumption of analgesic treatment in a diary. The proportion of patients who took oral pain medication and the treatment categories will be compared between the 2 groups. from the end of the root canal treatment (Day 0) to Day 7
Secondary Adverse events Adverse events reported by patients on a diary from Day 0 to Day 7 and adverse events clinically observed by the dental surgeon at each follow-up visit will be used to assess the safety of root canal sealers and endodontic procedures from the end of the root canal treatment (Day 0) to 5 years
See also
  Status Clinical Trial Phase
Completed NCT04935736 - Postoperative Pain After Root Canal Obturation With Sealer Containing Prednisolone. N/A
Completed NCT04885686 - Endodontic Post-operative Pain Evaluation of Patients After Using Endomethasone N or Endomethasone SP (EndoPOP) N/A
Completed NCT01728532 - Open, Multicentric Trial Evaluating the Efficacy and the Clinical Tolerance of PA0903 as Root Canal Sealer N/A
Completed NCT04753138 - Outcome of SBO With Calcium Silicate Sealer vs WVC With Resin Based Sealer N/A
Recruiting NCT05247138 - Measurement of the Clinical and Radiological Performance Impact of the Root Canal Treatment With BioRootTM RCS.
Completed NCT03732170 - Root Canal Treatment With TotalFill® Bioceramic Sealer and AH Plus® Sealer N/A
Completed NCT03874949 - Pain After Root Canal Obturation With Sealer Containing or Not 1% Enoxolone N/A